Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With $135M rights deal, Questcor locks up rival to its pricey Acthar drug
With $135M rights deal, Questcor locks up rival to its pricey Acthar drug
With $135M rights deal, Questcor locks up rival to its pricey Acthar drug
Submitted by
admin
on June 17, 2013 - 3:01pm
Source:
Fierce Pharma
News Tags:
Questcor
H.P. Acthar Gel
Novartis
Headline:
With $135M rights deal, Questcor locks up rival to its pricey Acthar drug
Do Not Allow Advertisers to Use My Personal information
